Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction

Figures

• 

  Figure 1. Baseline factors independently associated with oral anticoagulant use at enrolment in patients with a history of atrial fibrillation (n=702).

• 

  Figure 2. Adjusted associations between history of atrial fibrillation and self-reported QoL at baseline. QoL, quality of life; VAS, visual analogue scale. Estimated using ordinal logistic regression models for index score, VAS score and each individual domain. OR >1 means that patients with a history of atrial fibrillation (AF) have poorer self-rated health than those with no history of AF. For instance, the adjusted common OR for VAS score is 1.17, which means that patients with a history of AF have 17% increased odds of being below any cut-off value (<90, <80, <70 or <60) for the EQ-5D VAS score compared with patients with no history of AF. Adjusted for factors associated with baseline EQ-5D index score (sex, age, body mass index, heart rate, smoking status, years of education, diabetes, history of stroke, angina, peripheral vascular disease, peptic ulcer disease, chronic obstructive pulmonary disease, heart failure, anaemia, emergency department visit within the preceding 6 months, type of index myocardial infarction, diuretic use and geographical region).

• 

  Figure 3. In patients without history of atrial fibrillation at enrolment (n=7575), baseline factors independently associated with development of incident atrial fibrillation after registry enrolment. ED, emergency department; EQ-5D, EuroQoL five dimensions questionnaire.

• 

  Figure 4. Cumulative incidence of (A) all-cause mortality, (B) bleeding requiring hospitalisation, (C) primary composite outcome and (D) secondary composite outcome in patients with a history of atrial fibrillation at enrolment. Primary composite outcome: all-cause mortality, MI, stroke, unstable angina requiring urgent revascularisation. Secondary composite outcome: cardiovascular mortality, MI, stroke AF, atrial fibrillation. MI, myocardial infarction.

• 

  Figure 5. Occurrence of (A) all-cause hospitalisation (p<0.001), (B) cardiovascular hospitalisation (p<0.001) and (C) bleeding requiring hospitalisation (p=0.007) during follow-up by history of atrial fibrillation at enrolment. The p value was calculated to compare patients with no history of AF and patients with a history of AF. AF, atrial fibrillation.